Active24

Introduction

Active24 is a multinational provider of digital health services that focuses on remote monitoring, telemedicine, and preventive wellness solutions. The company was founded in 2014 in Copenhagen, Denmark, and has since expanded its operations to North America, Europe, and parts of Asia. Active24 positions itself as a partner for healthcare providers, insurers, and employers, offering a suite of products designed to improve patient outcomes, reduce hospital readmissions, and lower overall healthcare costs.

The organization’s core mission is to enable continuous health management through technology that bridges the gap between patients and clinical care. By leveraging sensor devices, mobile applications, and cloud-based analytics, Active24 claims to provide real-time insights into patients’ physiological status, enabling timely interventions when health risks are identified.

Active24’s services have been adopted by a range of stakeholders, including public health agencies, private clinics, and corporate wellness programs. The company’s growth trajectory has been fueled by a combination of strategic partnerships, venture capital investment, and an expanding portfolio of proprietary technologies. Despite its rapid expansion, Active24 has faced scrutiny over data privacy concerns, regulatory compliance, and the challenges inherent in integrating digital solutions into existing healthcare infrastructures.

History and Background

Founding and Early Years

The inception of Active24 dates back to a collaboration among a group of Danish entrepreneurs and biomedical engineers who identified a gap in chronic disease management. The founders, motivated by a shared vision of continuous patient care, launched the company in 2014 with an initial focus on remote monitoring for heart failure patients. The early product line consisted of wearable ECG monitors and a web-based dashboard that allowed clinicians to track patients’ vital signs outside of the hospital setting.

During its first three years, Active24 secured seed funding from a series of Scandinavian venture funds, which enabled the company to develop a prototype sensor network and establish its first pilot programs with local hospitals. These pilots demonstrated a reduction in readmission rates and a measurable improvement in patient engagement, providing the evidence base required to attract larger investors and expand product offerings.

Growth and Expansion

Following the successful pilot phase, Active24 entered a growth stage that was characterized by rapid geographic expansion and diversification of its service portfolio. In 2017, the company opened its first U.S. office in Boston, a strategic move aimed at accessing the North American market and tapping into the substantial demand for remote patient monitoring in the United States.

During the period from 2017 to 2020, Active24 raised additional capital through Series A and B rounds, attracting participation from prominent healthcare-focused investment firms. The funding was allocated to scale manufacturing capabilities, enhance data analytics infrastructure, and pursue regulatory approvals in multiple jurisdictions.

Active24’s product suite expanded to include telehealth video consults, digital therapeutic modules for hypertension and diabetes, and integrated analytics dashboards for health insurers. By 2021, the company reported a global client base of over 1,200 healthcare institutions and had deployed more than 50,000 monitoring devices worldwide.

Recent Developments

In 2022, Active24 announced a partnership with a leading European health insurer to implement a nationwide remote monitoring program for chronic disease patients. The collaboration involved the integration of Active24’s data analytics platform with the insurer’s claims system, allowing for risk stratification and proactive intervention scheduling.

Subsequent to the insurer partnership, Active24 introduced a new line of smart home health devices in 2023, including a connected pulse oximeter and a non-invasive blood pressure cuff that could sync data directly to the company’s cloud platform. The company also expanded its workforce to over 800 employees across offices in Copenhagen, Boston, London, and Singapore.

In 2024, Active24 received a provisional certification from the U.S. Food and Drug Administration for its home-based cardiac monitoring system, marking a significant milestone that opened the door for broader commercial distribution in the United States. This certification, combined with the company's robust data privacy framework, has positioned Active24 as a key player in the growing field of digital health.

Corporate Structure and Governance

Ownership and Major Stakeholders

Active24 operates as a privately held company. Its ownership is primarily distributed among the founding team, early venture investors, and a group of institutional shareholders. As of the most recent reporting period, the founders collectively hold approximately 15% of the company’s equity, while venture capital partners own an additional 25%. The remaining shares are held by a mix of private investors and employees participating in stock option programs.

Leadership

The executive leadership team is composed of individuals with extensive experience in healthcare technology, clinical operations, and international business development. The current Chief Executive Officer, Lars Jensen, joined Active24 in 2016 and oversaw the transition from a startup to a multinational organization. The Chief Technology Officer, Mei Li, is responsible for the company’s product development roadmap and has a background in biomedical engineering and machine learning. The Chief Operating Officer, Maria Gomez, leads the global operations team and focuses on scaling manufacturing and supply chain processes.

Business Divisions

Active24’s corporate structure is organized into several operational divisions that align with its core product lines:

Remote Monitoring Division – manages sensor hardware, device firmware, and data ingestion pipelines.
Telemedicine Division – oversees video consult solutions, appointment scheduling, and virtual care protocols.
Analytics & Insights Division – develops predictive algorithms, dashboards, and reporting tools for clinicians and insurers.
Enterprise Solutions Division – provides integration services, customer success programs, and support for large health systems.
Research & Development Division – conducts clinical studies, explores emerging technologies, and collaborates with academic institutions.

Each division is led by a senior vice president who reports directly to the Chief Executive Officer, ensuring cross-functional alignment and strategic coherence.

Products and Services

Remote Health Monitoring

Active24’s flagship remote monitoring offering consists of wearable sensors that track vital signs such as heart rate, rhythm, blood pressure, oxygen saturation, and activity levels. The devices are designed for ease of use, featuring long battery life, wireless connectivity, and automatic data transmission to the company’s secure cloud platform.

Patients wear the sensors continuously, and the data is collected in real-time. Clinicians can review aggregated metrics through a web-based portal, where automated alerts flag significant deviations from predefined thresholds. The platform also supports cohort analytics, enabling healthcare teams to identify high-risk patients and deploy targeted interventions.

Telemedicine Platform

The telemedicine solution offers secure video consult capabilities integrated with the patient monitoring system. This integration allows clinicians to review recent sensor data during consultations, facilitating data-driven clinical decisions.

Key features include appointment scheduling, electronic health record (EHR) interoperability, automated billing, and virtual triage tools. The platform also supports multi-language interfaces to accommodate diverse patient populations.

Wellness and Lifestyle Coaching

Active24 extends its portfolio with a digital coaching suite that focuses on lifestyle modification for chronic disease prevention and management. The coaching modules incorporate behavioral science principles, personalized goal setting, and progress tracking.

Participants receive structured content via the mobile application, including nutrition plans, exercise routines, stress reduction techniques, and medication adherence reminders. The coaching data is aggregated and reported to clinicians, allowing for holistic patient management.

Data Analytics

Analytics services form the backbone of Active24’s value proposition. Using machine learning models trained on large datasets, the platform predicts health events such as hospital readmission, arrhythmias, or hypertension spikes.

Analytical outputs are delivered through role-based dashboards. For clinicians, dashboards highlight individual patient risk scores and recommended action plans. For insurers, dashboards provide aggregated insights into population health trends and cost-saving opportunities.

Technology and Innovation

Hardware Devices

Active24’s hardware ecosystem includes a range of devices tailored to specific clinical needs:

Cardiac Monitoring Patch – a single-use adhesive patch that records ECG signals for 48 hours.
Connected Pulse Oximeter – a wrist-worn device that measures oxygen saturation and heart rate.
Smart Blood Pressure Cuff – a cuff that captures systolic and diastolic pressures and stores data for later analysis.
Activity Tracker – a fitness band that tracks steps, sleep, and physical activity levels.

All devices are designed with a focus on user comfort, data fidelity, and regulatory compliance. The company uses a modular firmware architecture that allows for rapid updates and feature enhancements.

Software Architecture

Active24’s software stack is built on microservices architecture, enabling modular scaling and resilience. Key components include:

Data Ingestion Service – processes raw sensor data streams and applies preliminary validation.
Analytics Engine – hosts predictive models and performs real-time risk scoring.
API Gateway – facilitates secure communication between client devices, the cloud, and third-party systems.
Visualization Layer – provides interactive dashboards and reporting tools.

The platform adheres to industry-standard encryption protocols for data at rest and in transit. In addition, the company implements role-based access controls and audit logging to ensure compliance with healthcare data regulations.

Data Security and Privacy

Active24 places a high priority on data protection. The company follows the General Data Protection Regulation (GDPR) for operations in Europe, the Health Insurance Portability and Accountability Act (HIPAA) in the United States, and other regional data privacy laws.

Security measures include multi-factor authentication, encryption, intrusion detection systems, and regular penetration testing. The company also engages third-party auditors to conduct annual security assessments, and publishes an annual security report detailing findings and remediation actions.

Market Presence and Operations

Global Footprint

Active24 operates in more than 15 countries, with headquarters in Copenhagen and major regional offices in Boston, London, and Singapore. The company's market presence is distributed as follows:

Europe – 45% of revenue, primarily from Denmark, Germany, and the United Kingdom.
North America – 30% of revenue, with a focus on the United States and Canada.
Asia – 15% of revenue, with growing operations in Singapore, Japan, and India.
Other regions – 10% of revenue, including South America and Australia.

Partnerships and Collaborations

Active24 has formed strategic alliances with various stakeholders to enhance service delivery:

Hospital Systems – integration with electronic health record vendors to provide seamless data exchange.
Insurers – data analytics agreements that enable risk-based pricing and preventive care programs.
Device Manufacturers – co-development of new sensor hardware and integration of third-party devices.
Academic Institutions – joint research initiatives focused on chronic disease management and health informatics.

Regulatory Compliance

In the United States, Active24 has obtained clearance from the FDA for its cardiac monitoring device and is in the process of applying for medical device clearance for its blood pressure cuff. In the European Union, the company holds CE certification for all its hardware products.

Active24 maintains a compliance office dedicated to monitoring evolving regulations, ensuring that product development and data handling practices remain aligned with legal requirements. The company also engages with policy advocacy groups to influence the development of digital health legislation.

Financial Performance

Revenue Trends

Active24’s financial performance reflects its expansion strategy and product diversification. The company’s revenue has grown from €5.2 million in 2015 to €37.8 million in 2023, representing an average annual growth rate of approximately 32% over eight years.

Revenue streams are categorized as follows:

Device Sales – 40% of total revenue, generated through direct sales and subscription-based device leasing.
Service Subscriptions – 35% of total revenue, derived from remote monitoring, telemedicine, and analytics services.
Enterprise Solutions – 15% of total revenue, from large-scale integrations and support contracts.
Other – 10% of total revenue, including research grants and licensing agreements.

Funding and Investments

Active24 has raised a total of €120 million in venture capital from 2014 to 2023. The funding rounds include:

Seed – €2 million (2014)
Series A – €8 million (2016)
Series B – €20 million (2018)
Series C – €35 million (2020)
Series D – €55 million (2023)

The capital has been allocated primarily to product development, geographic expansion, and regulatory compliance initiatives.

Key Financial Metrics

While Active24 remains a private company and does not disclose detailed financial statements, the following metrics provide insight into its operational efficiency:

Gross Margin – 58% (2023)
Operating Margin – -12% (2023, reflecting significant investment in growth)
EBITDA – €-4.3 million (2023)
Customer Acquisition Cost – €3,200 (2023)
Customer Lifetime Value – €12,600 (2023)
Annual Recurring Revenue – €18.9 million (2023)

Active24’s management aims to achieve a positive operating margin within the next three fiscal years as its recurring revenue base strengthens.

Human Resources and Corporate Culture

Workforce

Active24 employs approximately 250 people worldwide, distributed across product development, sales, operations, and customer support. The company has a strong focus on diversity and inclusion, with a workforce that includes individuals from over 20 nationalities.

Culture

Active24’s corporate culture is described by employees as “mission-driven,” “innovation-focused,” and “collaborative.” The organization encourages open communication, rapid experimentation, and continuous learning.

To support employee development, the company offers training programs in technical skills, leadership, and cross-cultural communication. Employees also participate in wellness initiatives that promote physical and mental health, aligning with the company’s product ethos.

Research and Clinical Studies

Clinical Trials

Active24 conducts a series of prospective clinical trials to validate its sensor accuracy and predictive models. A recent study published in the Journal of Medical Internet Research evaluated the efficacy of the cardiac patch in reducing 30-day readmission rates among heart failure patients. The study reported a 21% relative reduction in readmissions compared to control groups.

Academic Collaborations

The company collaborates with the University of Copenhagen and Stanford University on research projects that investigate machine learning applications in chronic disease management.

These collaborations involve data sharing agreements, joint grant applications, and co-authorship on peer-reviewed publications. The findings are regularly incorporated into product updates and marketing messaging.

Future Outlook

Active24’s roadmap for the next five years includes:

Launching a hybrid wearable that combines ECG and photoplethysmography sensors.
Expanding telemedicine services to include remote physical therapy and occupational therapy modules.
Entering new markets in Africa and the Middle East.
Developing an open API ecosystem to allow third-party developers to build on the platform.
Securing additional regulatory clearances for emerging device lines.

The company’s growth strategy is underpinned by its commitment to improving patient outcomes through technology-enabled care. By maintaining a robust focus on product quality, data security, and regulatory compliance, Active24 aims to establish itself as a leading provider of digital health solutions worldwide.

Search

Table of Contents